Health In Tech, Inc. (HIT)
Health In Tech, Inc. brought in $36M of revenue over the twelve months to June 30, 2026, up 28.9% from a year earlier. It posted a net loss of $3.9M. At June 30, 2026 it held $6.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Key facts about Health In Tech, Inc.
- Net worth
- Health In Tech, Inc. has a market value (market cap) of $38.9M at the latest share price, and shareholders' equity of $19.6M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $37.6M (+91.7% year on year), with net income of $1.3M. Over the 12 months to June 30, 2026: revenue $36M, net loss $3.9M.
- Cash flow
- In fiscal 2025 operations brought in $3.1M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Health In Tech, Inc.'s next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Health In Tech, Inc. does
Health In Tech, Inc. is registered with the SEC under industry code SIC 6411 (Insurance Agents, Brokers & Service). Its shares trade on NASDAQ under the ticker HIT.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $37.6M | $1.3M | $0.02 | n/a |
| 2024 | $19.6M | $670.5K | $0.01 | n/a |
| 2024 | $19.2M | $2.5M | n/a | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where HIT ranks in Finance
Latest SEC filings
What Health In Tech, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 1, 2026Preliminary proxy statement PRE 14A
- September 30, 2026
- September 29, 2026Passive stake (5% or more) SCHEDULE 13G
- September 4, 2026
- August 13, 2026
- August 13, 2026
- August 13, 2026
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 15% to $8.1M versus the same quarter last year; diluted EPS -$0.04 versus $0.01.
- June 26, 2026
- June 10, 2026
Insider trades
What the people running Health In Tech, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $37.7K worth of shares in the last 90 days and bought none on the open market. 28% of the selling was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 15, 2026 | Johnson Tim DonaldChief Executive Officer, Director, 10% owner | Shares withheld for tax | 63,339 | $56.4K |
| September 15, 2026 | Qian LinLinChief Executive Officer, Director, 10% owner | Shares withheld for tax | 33,725 | $30K |
| September 15, 2026 | Hasan Zain SyedChief Growth Officer | Shares withheld for tax | 4,795 | $4.3K |
| September 14, 2026 | Hayes TimothyDirector | Sold | 12,000 | $10.7K |
| September 11, 2026 | Hasan Zain SyedChief Growth Officer | Soldpre-planned (10b5-1) | 11,667 | $10.7K |
| September 11, 2026 | Hayes TimothyDirector | Sold | 12,000 | $10.9K |
| September 9, 2026 | Hayes TimothyDirector | Sold | 5,730 | $5.3K |
| August 13, 2026 | Hasan Zain SyedChief Growth Officer | Shares withheld for tax | 4,007 | $4.2K |
Who owns HIT
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Tim Johnson13G, passive | 60.4% | February 14, 2025 |
| LinLin Qian13G, passive | 24.4% | February 14, 2025 |
| Lytton Laurence W13G, passive | 6.2% | September 29, 2026 |
Largest institutional holders
Insiders
8 insiders reported holding 32,916,471 shares in total, about $19.5M at the last price.
| Holder | Shares |
|---|---|
| Johnson Tim DonaldChief Executive Officer, Director, 10% owner | 23,271,026 |
| Qian LinLinChief Executive Officer, Director, 10% owner | 8,964,667 |
| Hasan Zain SyedChief Growth Officer | 183,749 |
| Lockett Jonathan DelChief Strategy Officer | 143,539 |
| Howard William D.Director | 138,510 |
| Hayes TimothyDirector | 108,780 |
| Shrestha Sanjay KDirector | 101,200 |
| McStravock JohnGeneral Counsel | 5,000 |
Questions about HIT
What does Health In Tech, Inc. do?
Health In Tech, Inc. is a company in the Finance sector, listed on NASDAQ as HIT. Its shares trade on NASDAQ under the ticker HIT.
What is Health In Tech, Inc.'s net worth?
Health In Tech, Inc. has a market value (market cap) of $38.9M at the latest share price, and shareholders' equity of $19.6M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Health In Tech, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $3.9M on revenue of $36M.
How much revenue does Health In Tech, Inc. make?
Over the twelve months to June 30, 2026 Health In Tech, Inc. reported revenue of $36M. That is 28.9% more than a year earlier.
When did Health In Tech, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the preliminary proxy statement from October 1, 2026.
When is Health In Tech, Inc.'s next earnings report?
Health In Tech, Inc.'s next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare HIT with
Follow HIT
Get an email when Health In Tech, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Health In Tech, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.